UOC
TVGN icon

UBS O'Connor’s Tevogen Inc TVGN Stock Holding History

UBS O'Connor’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,452
Closed -$4.88M – 735
2022
Q4 		$4.88M Sell
9,452
-93
-1% -$47.6K 0.09% 158
2022
Q3 		$4.85M Sell
9,545
-955
-9% -$482K 0.06% 226
2022
Q2 		$5.25M Hold
10,500
– – 0.05% 226
2022
Q1 		$5.25M Buy
+10,500
New +$5.22M 0.06% 199

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS O'Connor's TVGN Position: Q1 2023 in Review

UBS O'Connor sold out of Tevogen Inc (TVGN) in Q1 2023, closing a stake of 9,452 shares — an estimated $4.88M sold.

UBS O'Connor first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $5.25M in Q2 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • UBS O'Connor reported no remaining Tevogen Inc position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 9,452 Tevogen Inc shares in Q1 2023, an estimated $4.88M.
  • UBS O'Connor first reported a position in Tevogen Inc in Q1 2022 and held it in 4 quarters.
  • UBS O'Connor's Tevogen Inc position peaked at $5.25M in Q2 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Inc as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.